Literature DB >> 30873625

Electrocardiographic modifications induced by breast implants.

Sok-Sithikun Bun1, Philippe Taghji2, Abdelkarim Errahmouni3, Decebal Gabriel Laţcu1, Alaa Al Amoura4, Bogdan Enache1, Thomas Hugues1, Khelil Yaïci1, Nadir Saoudi1.   

Abstract

BACKGROUND: Echocardiography realization can be challenging in the presence of breasts implants (BI). It is less known if electrocardiograms (ECG) may be modified in the presence of BI.
METHODS: ECG from women with BI (and without any known cardiac structural disease) were sent and analyzed by two experienced electrophysiologists (EP1 and EP2) who were blinded and completely unaware of the context of the patients (Group 1). ECG from a control matched-group of female women without BI (Group 2) were also blindly sent for analysis.
RESULTS: ECG were collected from 28 women with BI (42 ± 8 years) without any acute medical condition. A proportion of 42% of the ECG were considered abnormal by EP1 and 46% by EP2. The abnormalities were for EP1: negative T waves (5), ST depression in inferolateral leads (2), absence of R wave progression from V1 to V4 (4), left ventricular (LV) hypertrophy (1), long QT(1), early repolarization (1), short PR (1); For EP2: negative T waves (6), ST depression in inferolateral leads (2), absence of R wave progression from V1 to V4 (4), LV hypertrophy(3), long QT (1), early repolarization (1). ECG from group 2 were considered abnormal in only 1 patient (5%) for EP1, and normal in all for EP2 (P = 0.0002 between the groups).
CONCLUSIONS: ECG from women with BI were considered abnormal in 42% to 46% of the cases by expert readers. ECG interpretation can thus be misleading in these women.
© 2019 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc.

Entities:  

Keywords:  ECG modifications; breasts implants

Mesh:

Year:  2019        PMID: 30873625      PMCID: PMC6522987          DOI: 10.1002/clc.23174

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


breasts implants electrocardiogram/electrocardiographic electrophysiologist structural heart disease

INTRODUCTION

Different anatomical chest variations/structures are responsible for electrocardiographic (ECG) modifications in patients without heart disease. Chronic obstructive pulmonary disease is often associated with a decrease in voltage amplitude in all the ECG leads. Other anatomic variations like pectus excavatum,1 or situs inversus2 may induce ECG modifications. Doing an echocardiography may be challenging in the presence of breasts implants (BI), as the ultrasound transmissions are impaired by the protheses structure.3 It is less known if an ECG may be modified by the presence of BI.

METHODS

Patient selection

Twelve‐lead ECGs obtained from women with BI were sent and analyzed by two experienced electrophysiologists (EP1 and EP2) who were blinded and completely unaware of the context (Group 1). None of the women had BI because of reconstructive surgery (breast cancer). The women gave their consent for their ECG to be collected for the purpose of the study. ECGs from a control group of women without BI (Group 2, n = 20) were also randomly and blindly sent for analysis. The control group included women from our nurse and paramedical staff. Exclusion criteria were: age > 55, any cardiovascular sign/disease (hypertension, stroke or congestive heart failure, diabetes, and dyslipidemia as defined by low‐density lipoprotein [LDL]‐cholesterol ≥160 mg/dL if age comprised between 20 and 39 years; or LDL‐cholesterol ≥70 mg/dL if age above 40 years). All the ECGs were exclusively performed by the nursing staff of our department and special care was taken to place the electrodes in a correct and reproducible position, despite the presence of BI (Group 1): fourth intercostal space on the right (V1) and left (V2) border of the sternum, V4 on the fifth intercostal space on the midclavicular line, V3 midway between V2 and V4, V5 on the anterior axillary line on the same horizontal level as V4, and V6 on the mid‐axillary line on the same horizontal level as V4 and V5. All the women from both groups had an echocardiography to check for any structural heart disease (SHD) that could likely explain their ECG modification. The electrophysiologists were asked to report the abnormalities using either the Novacode or Minnesota code as follow: left ventricular (LV) hypertrophy without ST‐T abnormalities (Novacode 6.1.0) measured with the Sokolow‐Lyon index; negative T waves were considered significant if associated with a negative phase at least 1.0 mm, but not as deep as 5.0 mm (Minnesota code 5‐2). ST depression in inferolateral leads was considered significant if comprised between 1.0 and 2.0 mm with ST segment horizontal or downward sloping (Minnesota code 4‐1‐2); absence of R wave progression (Minnesota code 1‐2‐8). The cutoff for long corrected QT (Bazetts formula) was 460 ms. Early repolarization was noted if fulfilling the last consensus conference, that is, QRS duration <120 ms, with Jp 0.1 mV in two or more contiguous leads of the 12‐lead ECG excluding V1 to V3, and presence of an end‐QRS notch or slur on the prominent R‐wave.4

Statistical analysis

The statistical analysis was completed using GraphPad Prism 5 (San Diego, California). Numerical variables are expressed as mean ± SD. A Cohens Kappa test was used for inter‐observator agreement correlation.

RESULTS

ECGs were collected from 28 women with BI (mean age 42 ± 8 years; all of Caucasian origin except for one woman, who was from African origin). The mean time between the BI insertion and the ECG recording was 3.1 ± 2.4 years. Only one woman had an ECG before and after the insertion of her BI. None of the women had a personal history of SHD or known cardiovascular risk factors in the BI group, neither in the control group. There were no differences concerning the body mass index between the two groups (20.2 ± 5.8 in group 1 vs 22.9 ± 3.0 in group 2; P = 0.42). A proportion of 42% (12/28) of the ECGs was considered abnormal by EP1 and 46% (13/28) by EP2. The abnormalities (Table 1) were for EP1: negative T waves (5) (Figure 1A), ST depression in inferolateral leads (2) (Figure 1B), absence of R wave progression from V1 to V4 (4), LV hypertrophy (1), long QT (1), early repolarization (1), short PR (1) (Figure 1C).
Table 1

ECG analysis of patients with breasts implants

AgeElectrophysiologist 1Electrophysiologist 2
142Negative T waves from V1 to V4, absence of R wave progression from V1 to V4Negative T waves from V1 to V4, absence of R wave progression from V1 to V4
252ST depression from V3 to V6ST depression from V3 to V6
340Early repolarization in inferior leadsEarly repolarization in inferior leads
442Negative T waves from V1 to V4, absence of R wave progression from V1 to V4Negative T waves from V1 to V4, absence of R wave progression from V1 to V4
546Long QT (QTc = 480 ms)Long QT (QTc = 500 ms)
636Abnormal R transition from V1 to V4Left ventricular hypertrophy (Sokolow = 36 mm)
757NormalNormal
846NormalNormal
943ST depression in inferior leadsST depression in inferior leads
1039Absence of R wave progression from V1 to V4Left ventricular hypertrophy (Sokolow = 38 mm)
1131NormalNormal
1226NormalNegative T waves from V1 to V3, absence of R wave progression from V1 to V4
1342NormalNormal
1425NormalNormal
1530NormalNormal
1648NormalNormal
1758NormalNormal
1834Left ventricular hypertrophy (Sokolow = 35 mm)Left ventricular hypertrophy (Sokolow = 35 mm)
1950NormalNormal
2036NormalNormal
2123Negative T waves V1‐V2/Short PRNegative T waves V1‐V2, absence of R wave progression from V1 to V4
2242NormalNormal
2351NormalNormal
2441NormalNormal
2539NormalNormal
2638NormalNormal
2742Negative T waves in D3 VFNegative T waves in D3 VF
2836Negative T waves in V1 and V2Negative T waves in V1 and V2
Figure 1

Representative cases of 12‐lead electrocardiogram modifications observed in women with breast implants and absence of structural heart disease. A, T wave inversion from V1 to V3 (patient no. 1 from the table). B, Diffuse ST depression from V3 to V6 and in inferior leads (patient no. 9). C, Short PR interval and negative T waves in V1 V2 (patient no. 21). D, Negative T waves in V1 and V2 in a 36‐year‐old patient of African origin who experienced fainting (patient no. 28)

ECG analysis of patients with breasts implants Representative cases of 12‐lead electrocardiogram modifications observed in women with breast implants and absence of structural heart disease. A, T wave inversion from V1 to V3 (patient no. 1 from the table). B, Diffuse ST depression from V3 to V6 and in inferior leads (patient no. 9). C, Short PR interval and negative T waves in V1 V2 (patient no. 21). D, Negative T waves in V1 and V2 in a 36‐year‐old patient of African origin who experienced fainting (patient no. 28) For EP2, the abnormalities were: negative T waves (6), ST depression in inferolateral leads (2), absence of R wave progression from V1 to V4 (4), LV hypertrophy (3), long QT (1), early repolarization (1). The patient with a possible diagnosis of long QT had an adrenalin challenge to rule out any long QT syndrome; the patient with short PR did not elicit any preexcitation after an adenosine injection. A normal echocardiography also excluded any LV hypertrophy by the measurement of the interventricular septum diameter. The inter‐observator agreement was calculated at 92.3%. ECGs from group 2 (38 ± 7 years, all of Caucasian origin) were considered abnormal only in one woman of group 2 (5%) for EP1 (absence of R wave progression from V1 to V4), and all normal for EP2. The inter‐observator agreement was calculated at 96.4% in the control group.

DISCUSSION

The present study shows a significantly higher proportion of ECG modifications in women with BI and no SHD, when compared to women without BI. The implications may be important, because ECG interpretation can be completely misleading if the patient presents with a cardiovascular symptom/sign. A 42% to 46% of ECG modifications were reported in our study, which is significantly higher than the prevalence of ECG abnormalities reported in a very large population of non‐athlete young female subjects, including a vast majority of Caucasian ethnicity (7764 women), mainly involving QT abnormalities.5 This is in contrast with our findings (in almost only Caucasian young female after BI), which revealed ECG modifications such as negative T waves, ST depression in inferolateral leads or absence of R wave progression from V1 to V4 (abnormal QT interval accounted for less 4% of the cases in our study). Of note, in our study, the presence of BI affected the depolarization as well as the repolarization on the different ECGs analyzed. The ECG modifications were also more predominantly observed on the precordial (chest) leads, in comparison to the limb leads, which is more likely to be explained by the presence of the BI. In the BI group, two patients showed a short PR and long QT interval (PR and QT measured in lead II), respectively. These borderline intervals may represent the normal variations in the general population, and do not seem related to the BI themselves.6 T wave inversion and ST depression have sometimes been reported as nonspecific modifications in women, but they were considered “abnormal” enough for the two expert electrophysiologists to be reported.7, 8 Furthermore, the higher proportion of these ECG modifications is significant in comparison with the control group (none in the later). Figure 1D illustrates the case of a 36‐year‐old patient who was admitted for several episodes of fainting. She had no significant past medical history (but implanted with BI), and of African origin. There was a family history of unexplained sudden cardiac death (the father and the brother of the patient, respectively at the ages of 50 and 45). Despite normal morphological evaluation including echocardiography and cardiac MRI, we decided to insert an implantable loop recorder (Reveal Linq, Medtronic Inc, Minneapolis, Minnesota, USA.) in this patient because of the ECG « abnormalities ». Those ECG modifications were finally attributed to the presence of BI in this patient as no arrhythmia was recorded after 1 year of follow‐up with the implantable loop recorder, despite the recurrence of a vasovagal syncope. Literature on this subject is very limited. Previous work by Lu et al who reported normal ECGs in 10 out of 11 patients with silicone BI and all complaining of atypical chest pain.9 All patients had the BI removed and the authors concluded that silicone BI might induce atypical chest pain related to local inflammatory reactions. ECG modifications in women with BI may be explained by two mechanisms. The first one could be incorrect electrode placement (Appendix S1, Supporting Information). A significant volume of the BI may make the positioning of the electrodes more difficult in clinical practice (V1 to V3 may be more concerned for the positioning of the electrodes in the presence of BI). Peters et al reported a case of myocardial infarction mimicked by misplacement of the V2 and V3 leads because of a severe capsular contracture. The ECG normalized after an open capsulotomy on this patient.10 One possible hypothesis could be electrical vector deviations emanating from the heart, because the different wave fronts encounter an unexcitable region (silicone) before reaching the surface of the skin (Figure 2). This hypothesis is speculative, and needs be confirmed by experimental studies, but is an extension of the phenomenon observed with ultrasounds propagation in the presence of BI when performing an echocardiography.
Figure 2

Scheme explaining the deviation of the electrical wave front due to the presence of the breast implants acting as an unexcitable barrier

Scheme explaining the deviation of the electrical wave front due to the presence of the breast implants acting as an unexcitable barrier It may be a reasonable advice to suggest to women who are planning to have BI insertion to have an ECG before and keep it in their file to serve as a comparison for the future, in case of the appearance of any cardiovascular symptoms, in their medical history.

Limitations

This is a monocentric study. The number of women with ECGs before the insertion of BI is limited (n = 1). This is due to the fact that ECGs are not systematically recommended as part of the preoperative (anesthesiologist) visits in young women without SHD nor cardiovascular risk factors. A prospective study is needed, aiming to compare ECGs before BI insertion with post‐operative ECG. The data on the size of the BI in our population was not available to assess a possible correlation between the size of the BI and ECG modifications.

CONCLUSION

ECGs obtained from women with breasts implants were considered abnormal in 42% to 46% of the cases in comparison with a control group of women without breast implants (P = 0.0002). ECG interpretation can be misleading in the context of chest pain/acute coronary syndrome occurring in these patients.

CONFLICT OF INTEREST

The authors declare no potential conflict of interests. Appendix S1. Variations of the placement of the electrodes that may exaggerate the electrocardiographic modifications in the presence of breast implants (V3 and V4 in this illustration were intentionally placed in an incorrect position). Click here for additional data file.
  11 in total

1.  Resting ECG is modified after oophorectomy and regresses with estrogen replacement therapy in premenopausal women.

Authors:  V De Leo; A la Marca; E Agricola; G Morgante; S Mondillo; C Setacci
Journal:  Maturitas       Date:  2000-07-31       Impact factor: 4.342

2.  ECG image of the month. Mirror mirror.

Authors:  Tanyanan Tanawuttiwat; Samip Vasaiwala; Muhyaldeen Dia
Journal:  Am J Med       Date:  2010-01       Impact factor: 4.965

Review 3.  The Early Repolarization Pattern: A Consensus Paper.

Authors:  Peter W Macfarlane; Charles Antzelevitch; Michel Haissaguerre; Heikki V Huikuri; Mark Potse; Raphael Rosso; Frederic Sacher; Jani T Tikkanen; Hein Wellens; Gan-Xin Yan
Journal:  J Am Coll Cardiol       Date:  2015-07-28       Impact factor: 24.094

4.  Capsular contracture simulating myocardial infarction on ECG.

Authors:  W Peters; P McEwan
Journal:  Plast Reconstr Surg       Date:  1993-03       Impact factor: 4.730

5.  Prevalence of electrocardiographic anomalies in young individuals: relevance to a nationwide cardiac screening program.

Authors:  Navin Chandra; Rachel Bastiaenen; Michael Papadakis; Vasileios F Panoulas; Saqib Ghani; Jennifer Duschl; David Foldes; Hariharan Raju; Rebecca Osborne; Sanjay Sharma
Journal:  J Am Coll Cardiol       Date:  2014-02-26       Impact factor: 24.094

6.  Atypical chest pain syndrome in patients with breast implants.

Authors:  L B Lu; B O Shoaib; B M Patten
Journal:  South Med J       Date:  1994-10       Impact factor: 0.954

7.  Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality.

Authors:  Pablo Denes; Joseph C Larson; Donald M Lloyd-Jones; Ronald J Prineas; Philip Greenland
Journal:  JAMA       Date:  2007-03-07       Impact factor: 56.272

Review 8.  Interference of breast implants with echocardiographic image acquisition and interpretation.

Authors:  Mohammad-Reza Movahed
Journal:  Cardiovasc Ultrasound       Date:  2007-02-23       Impact factor: 2.062

9.  Brugada-type ECG associated with pectus excavatum.

Authors:  M Marchetti; M Sierecki; D Oriot; A Ghazali
Journal:  Images Paediatr Cardiol       Date:  2015 Jul-Sep

10.  Electrocardiographic modifications induced by breast implants.

Authors:  Sok-Sithikun Bun; Philippe Taghji; Abdelkarim Errahmouni; Decebal Gabriel Laţcu; Alaa Al Amoura; Bogdan Enache; Thomas Hugues; Khelil Yaïci; Nadir Saoudi
Journal:  Clin Cardiol       Date:  2019-03-28       Impact factor: 2.882

View more
  1 in total

1.  Electrocardiographic modifications induced by breast implants.

Authors:  Sok-Sithikun Bun; Philippe Taghji; Abdelkarim Errahmouni; Decebal Gabriel Laţcu; Alaa Al Amoura; Bogdan Enache; Thomas Hugues; Khelil Yaïci; Nadir Saoudi
Journal:  Clin Cardiol       Date:  2019-03-28       Impact factor: 2.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.